Europe Sleep Aids market was valued at $ 22,840.5 million in 2021 and will grow by 6.5% annually over 2021-2031, driven by the rising geriatric population and increasing incidences of sleep disorders, the increase in awareness about sleep disorders, the advancement of novel sleep aid products, a number of government initiatives to improve public healthcare, the increasing number of healthcare facilities, and the growing usage of portable and wearable sleep apnea devices. Highlighted with 32 tables and 52 figures, this 117-page report “Europe Sleep Aids Market 2021-2031 by Product Type (Smart Bedding, Lab Services, Sleep Apnea Devices, Medication, Wearable Devices, Others), Indication (Insomnia, Sleep Apnea, Narcolepsy, Restless Leg Syndrome, REM Sleep Behavior Disorder, Sleepwalking, Others), Distribution Channel (Drug Stores, E-Commerce, Hospital Pharmacies, Retail Pharmacies), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Europe Sleep Aids market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2019-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Europe Sleep Aids market in every aspect of the classification from perspectives of Product Type, Indication, Distribution Channel, and Country. Based on Product Type, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Smart Bedding • Sleep Lab Services • Sleep Apnea Devices o Adaptive Servo-Ventilators (ASVs) o Positive Airway Pressure (PAP) Devices o Oral Appliances o Facial Interfaces o Other Sleep Apnea Devices • Medication o Prescription Drugs o OTC Drugs o Herbal Drugs • Wearable Devices • Other Product Types Based on Indication, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Insomnia • Sleep Apnea • Narcolepsy • Restless Leg Syndrome • REM Sleep Behavior Disorder • Sleepwalking • Other Indications By Distribution Channel, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Drug Stores • E-Commerce • Hospital Pharmacies • Retail Pharmacies Geographically, the following national/local markets are fully investigated: • Germany • UK • France • Spain • Italy • Netherlands • Rest of Europe (further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland) For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Product Type, Indication and Distribution Channel over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: Advanced Brain Monitoring Inc. Apex Medical Corp. Apnea Sciences Corporation BMC Medical Co., Ltd. Braebon Medical Corp. Cadwell Industries Inc. Cleveland Medical Devices Inc. Compumedics Limited Drive DeVilbiss Healthcare Inc. Fisher & Paykel Healthcare Corp. Ltd. GlaxoSmithKline plc Itamer Medical Ltd. Koninklijke Philips N. V. Merck & Co., Inc. Natus Medical Inc. Nihon Kohden Corporation Pfizer Inc. ResMed Inc. Sanofi S. A. Sleep Number Corporation SleepMed Inc. SomnoMed Inc. Teva Pharmaceutical Industries Ltd. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)